Mesoblast
MESO
#4330
Rank
C$3.34 B
Marketcap
C$25.99
Share price
3.59%
Change (1 day)
69.20%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : C$0.25 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are C$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30C$0.25 B16.39%
2023-06-30C$0.22 B4.35%
2022-06-30C$0.21 B5.01%
2021-06-30C$0.20 B-19.09%
2020-06-30C$0.25 B11.71%
2019-06-30C$0.22 B16.29%
2018-06-30C$0.19 B6.7%
2017-06-30C$0.18 B-10.64%
2016-06-30C$0.20 B-48.41%
2015-06-30C$0.39 B11.99%
2014-06-30C$0.34 B31.2%
2013-06-30C$0.26 B8.31%
2012-06-30C$0.24 B3.17%
2011-06-30C$0.23 B14016.71%
2010-06-30C$1.68 M24.05%
2009-06-30C$1.36 M-15.01%
2008-06-30C$1.6 M116.26%
2007-06-30C$0.74 M-85.11%
2006-06-30C$4.97 M81.97%
2005-06-30C$2.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
C$0.16 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C$4.36 M-98.32% Bahamas